×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Clinical Trial Regulation: State of Play – Are We Ready?
Session Chair(s)
Ann Marie Janson Lang
Medical Products Agency (MPA) Co-Chair, Clinical Trials Facilitation
and Coordination Group (under Heads of Medicines Agencies), Sweden
Clinical Trial Regulation: State of Play – Are We Ready?
Speaker(s)
Panelist
Joel Passarinho, RPh
INFARMED, IP, Portugal
Head of Clinical Trials Unit
Panelist
Representative Invited
National Institute of Pharmacy and Nutrition
Ethics Committee Perspective
Outi Konttinen
National Committee on Medical Research Ethics (TUKIJA), Finland
General Secretary
Panelist
Ruediger Pankow, DrSc
Germany
Regulatory Affairs Expert, CTIS SME and PO
Panelist
Judith Creba, PhD
Novartis Pharma AG, Switzerland
Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU
Panelist
Agnes Mathieu-Mendes, RPh
European Commission, Belgium
Deputy Head of Unit
Have an account?